Chart calendar Galapagos NV
Upcoming events on Galapagos NV
Past events on Galapagos NV
2024-06-15 06:15 am | European Hematology Association Hybrid Congress - Abstract No #S243 |
2024-05-13 | RBC Capital Markets Global Healthcare Conference |
2024-05-03 08:00 am | Q1 2024 Earnings Call |
2024-05-02 04:01 pm | Q1 2024 Earnings Release |
2024-04-30 09:00 am | Extraordinary Shareholders Meeting |
2024-04-30 08:00 am | Annual General Meeting |
2024-04-17 08:06 am | European Society for Blood and Marrow Transplantation Meeting - Oral Number: OS16-05 |
2024-04-17 07:57 am | European Society for Blood and Marrow Transplantation Congress - Oral Number: OS16-04 |
2024-04-15 01:00 pm | European Society for Blood and Marrow Transplantation Congress - Poster Number: A073 |
2024-04-14 03:30 am | European Society for Blood and Marrow Transplantation Congress - Poster number: P049 |
2024-03-13 | Barclays Global Healthcare Conference |
2024-03-04 | TD Cowen Health Care Conference |
2024-02-23 08:00 am | Q4 2023 Earnings Call |
2024-02-22 04:01 pm | Q4 2023 Earnings Release |
2024-02-17 02:30 am | EBMT EHA European CAR T Cell Meeting - Poster No: AS-CART-2024-00103 |
2024-02-16 12:38 pm | EBMT EHA European CAR T Cell Meeting - Oral No: AS-CART-2024-00099 |
2024-02-15 02:15 pm | EBMT EHA European CAR T Cell Meeting - Poster No: AS-CART-2024-00104 |
2024-02-15 01:45 pm | EBMT EHA European CAR T Cell Meeting - Poster Number: AS-CART-2024-00090 |
2024-02-15 01:45 pm | EBMT EHA European CAR T Cell Meeting - Poster No: AS-CART-2024-00090 |
2024-02-14 | European Society for Blood and Marrow Transplantation -European Hematology Association Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 896 924 -3.07% | 530 484 9.64% | 485 483 0.39% | 505 545 -7.33% | 784 550 42.49% | 296 |
EBITDA Million EUR | Released Forecast Spread | 383 438 -12.64% | -160 -183 12.71% | -131 -213 38.45% | -202 -137 -47.34% | 0,00 -230 - | -103 |
EBIT Million EUR | Released Forecast Spread | 370 417 -11.29% | -179 -241 25.85% | -166 -221 25.16% | -268 -192 -39.01% | 129 -148 187.11% | -108 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 150 256 -41.49% | -310 -283 -9.58% | -123 -194 36.75% | -215 -71,5 -200.9% | 0,00 8,44 - | -8,56 |
Net income Million EUR | Released Forecast Spread | 150 270 -44.5% | -305 -316 3.45% | -103 -176 41.37% | -218 -69,5 -213.65% | 212 -52,8 500.82% | -22,3 |
EPS EUR | Released Forecast Spread | 2,49 5,29 -52.9% | -4,69 -4,33 -8.41% | -1,58 -2,55 37.97% | -3,32 -1,08 -206.08% | 3,21 -1,58 302.72% | -0,60 |
Announcement Date | 20/02/20 | 18/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 144 86,6 66.29% | 138 119 15.45% | 274 111 146.85% | 136 121 12.9% | 95,1 99,3 -4.2% | 179 107 66.77% | 150 113 33.19% | 120 102 18% | 335 110 203.65% | 62,4 82,9 -24.71% | 60,6 | 60,9 | 64,7 | 55,9 | 55,9 |
EBITDA Million EUR | Released Forecast Spread | -44,0 -43,7 -0.84% | -111 -60,1 -84.28% | -60,0 | -136 | -209 | ||||||||||
EBIT Million EUR | Released Forecast Spread | -21,1 -50,1 57.87% | -76,4 -39,3 -94.5% | -97,5 -54,0 -80.56% | -37,6 -99,0 62.03% | -132 -58,3 -127.21% | 22,0 -75,2 129.23% | -10,7 -53,8 80.13% | -30,2 -60,2 49.77% | 148 -77,3 291.41% | -33,1 -36,4 9.08% | -29,4 | -30,7 | -27,5 | -23,0 | -23,2 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -11,6 -50,4 76.98% | -18,2 -46,6 60.93% | 22,2 -104 121.49% | -208 -43,5 -376.86% | 23,5 -56,9 141.24% | 18,5 -43,5 142.41% | 25,7 -70,4 136.53% | -101 | 22,9 -8,61 366.27% | -4,64 | -7,71 | -16,2 | 5,88 | 5,66 | |
Net income Million EUR | Released Forecast Spread | -13,3 -50,4 73.6% | -19,0 -45,4 58.18% | 21,5 -104 120.77% | -207 -42,7 -384.88% | 23,2 -57,4 140.4% | 5,10 -43,6 111.69% | 25,8 -59,2 143.6% | 158 -72,0 318.95% | 90,2 -8,61 1147.45% | -4,64 | -7,71 | -16,3 | 5,88 | 5,66 | |
EPS EUR | Released Forecast Spread | -0,29 -0,73 60.14% | 0,33 -0,80 141.25% | -3,16 -0,60 -426.67% | 0,08 -0,86 109.26% | 0,39 -1,70 122.9% | 2,39 -3,72 164.29% | -0,21 | -0,19 | -0,28 | ||||||
Announcement Date | 05/05/22 | 04/08/22 | 04/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | 02/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-22 07:00 am | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Galapagos NV
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |